No Data
No Data
Investor Exchange Event Schedule - 20250427 - Annual Report Quarterly Report Conference Call
Vcanbio Cell & Gene Engineering Corp.,Ltd. (600645.SH): In the first quarter, the net income was approximately 28.03 million yuan, a decrease of 30.18% year-on-year.
Glory Capital reported on April 25 that Vcanbio Cell & Gene Engineering Corp., Ltd. (600645.SH) announced that revenue for the first quarter of 2025 is approximately 0.351 billion yuan, a year-on-year decrease of 11.86%; net income attributable to shareholders of the listed company is approximately 28.03 million yuan, a year-on-year decrease of 30.18%; and basic EPS is 0.06 yuan.
Zhongyuan Kyowa: Zhongyuan Kyowa Cell Genetic Engineering Co., Ltd. Report for the first quarter of 2025
Zhongyuan Kyowa: Summary of the 2024 Annual Report of Zhongyuan Kyowa Cytogenetic Engineering Co., Ltd.
Zhongyuan Kyowa: Zhongyuan Kyowa Cell Genetic Engineering Co., Ltd. 2024 Annual Report
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2024 Annual Report